Gilead Sciences has reached a $202 million settlement to resolve a civil fraud lawsuit accusing the company of paying ...

NEW YORK, April 29 (Reuters) - Gilead Sciences (GILD.O), opens new tab ... to doctors who agreed to prescribe its HIV drugs. The settlement announced on Tuesday by U.S. Attorney Jay Clayton ...

Over the years, a host of large drugmakers have inked settlements with the federal authorities to resolve allegations that ...

The U.S. Attorney's Office joined Bellman's lawsuit against Gilead. The settlement, which calls for Gilead to pay the U.S. nearly $177 million and the balance to various states, was approved ...

The company paid to settle allegations of paying kickbacks to doctors in exchange for prescribing several of its HIV ...

A patent dispute between ViiV Healthcare and Gilead Sciences has been resolved, with Gilead agreeing to pay a $1.25 billion settlement as well as royalties on sales of one of its top HIV products.

On April 29, 2025, the U.S. Attorney’s Office for the Southern District of New York (SDNY) announced a $202 million civil False Claims Act ...

Gilead Sciences agreed to pay $202 million to the ... prescribe Gilead's HIV drugs and drive up sales," Clayton said. The settlement, which calls for Gilead to pay the U.S. nearly $177 million ...

Gilead held dinners to promote its HIV medications at expensive restaurants that federal authorities claim were “wholly inappropriate” venues, Stat reported. Gilead said it settled to avoid the cost ...

Gilead Sciences agreed to pay $202 million to the ... prescribe Gilead's HIV drugs and drive up sales," Clayton said. The settlement comes a month after a federal judge in New Jersey ruled that ...